Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “normal”

47 pharma patents match "normal" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 47
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 47 pharmaceutical patents matching "normal" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

47 results for “normal” · 30,257 patents in full index Clear search

  1. US 12428463

    Chimeric antigen receptors targeting abnormal glycobiology

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 30, 2025 · Expires Sep 25, 2045

    granted

  2. US 12269808

    Amino dithioperacid thioester compound, preparation method therefor, and use thereof

    EAST CHINA NORMAL UNIVERSITY · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted

  3. US 12251458

    Anti-aging preparation for skin and application thereof

    SOUTH CHINA NORMAL UNIVERSITY · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted

  4. US 12234474

    Method to prevent the myelin abnormalites associated with arginase deficiency

    The Regents of the University of California · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted

  5. US 11793777

    Methods and compositions for treating conditions associated with an abnormal inflammatory response

    First Wave Bio, Inc. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted

  6. US 11760786

    Chimeric antigen receptors targeting abnormal glycobiology

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  7. US 11524017

    Method of using substrates of AKR1B1/AKR1B10 as anti-cancer drugs

    Beijing Normal University Hong Kong Baptist University United International College · Granted Dec 13, 2022 · Expires Dec 8, 2042

    granted

  8. US 11369627

    Myrtle polysaccharide P1, the separation method thereof and the use in preparing hypolipidemic drugs therefor

    South China Normal University School of Life Sciences · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  9. US 11111317

    Cordyceps militaris medium polysaccharide, method for separating and purifying same, and use thereof

    SOUTH CHINA NORMAL UNIVERSITY · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  10. US 10912746

    Methods and compositions for treating conditions associated with an abnormal inflammatory response

    First Wave Bio, Inc. · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted

  11. US 10905666

    Methods and compositions for treating conditions associated with an abnormal inflammatory response

    First Wave Bio, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

  12. US 10849867

    Methods and compositions for treating conditions associated with an abnormal inflammatory response

    First Wave Bio, Inc. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted

  13. US 10799468

    Methods and compositions for treating conditions associated with an abnormal inflammatory responses

    First Wave Bio, Inc. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  14. US 10774121

    Methods and compositions for treating neurodegenerative disorders and Alzheimer's Disease and improving normal memory

    The Regents of the University of California · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  15. US 10772854

    Methods and compositions for treating conditions associated with an abnormal inflammatory response

    First Wave Bio, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  16. US 10744103

    Methods and compositions for treating conditions associated with an abnormal inflammatory responses

    First Wave Bio, Inc. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted

  17. US 10420747

    Cancer treatment method using ailanthone compounds

    EAST CHINA NORMAL UNIVERSITY · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted

  18. US 10406158

    Methods and compositions for treating abnormal cell growth

    VERASTEM, INC. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  19. US 10292951

    Methods and compositions for treating conditions associated with an abnormal inflammatory responses

    First Wave Bio, Inc. · Granted May 21, 2019 · Expires May 16, 2039

    granted

  20. US 10221223

    Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

    The Regents of the University of California · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  21. US 10082496

    Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis

    The Board of Regents of the University of Texas System · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  22. US 10072051

    Anti-inflammatory lipopeptide and preparing method and application thereof

    EAST CHINA NORMAL UNIVERSITY · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  23. CA 3043000

    DERIVES DE PROSTAGLANDINE LIBERANT DE L'OXYDE NITRIQUE POUR LE TRAITEMENT DU GLAUCOME A TENSION NORMALE

    BAUSCH & LOMB [US] · Granted May 17, 2018 · Expires May 12, 2038

    granted

  24. US 9962385

    Methods and compositions for treating abnormal cell growth

    VERASTEM, INC. · Granted May 8, 2018 · Expires May 3, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.